Phase III PRESTIGE-AF trial shows that direct oral anticoagulants significantly lower the risk of ischemic stroke in ...

Research uncovers unexpected health risks and benefits in everyday beverages, from sodas to tea, reshaping our understanding ...

Common sites and sources of intracerebral hemorrhage. Intracerebral hemorrhages most commonly involve (A) cerebral lobes, originating from penetrating cortical branches of the anterior ...

Direct oral anticoagulants may lower stroke risk in people with prior intracerebral hemorrhage and atrial fibrillation. Part of this benefit was negated by an observed increased risk for secondary ...

A treatment tested by researchers in Boston found it improves motor function, coordination and spatial memory in mice. But it ...

A study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one day ...

A systematic review and meta-analysis of nine trials comparing non-vitamin K oral anticoagulants with low-dose aspirin revealed a link between rivaroxaban and higher rates of major bleeding and ...

Discover how a novel nasal spray could revolutionize traumatic brain injury treatment by reducing neuroinflammation and ...

Discover why daily beverage choices like tea, coffee, and fruit juice influence stroke risk across global populations.

Bioxodes raises €2.7 million from existing investors in Series A extensionInterim data from BIRCH intracerebral hemorrhage (ICH) Phase 2a trial in Q1 2025Recruitment of up to 16 additional patients ...

Researchers at Mass General Brigham found that a nasal spray delivering anti-CD3 (Foralumab) reduces neuroinflammation, ...

A new study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI).